Association between postoperative complications and clinical cancer outcomes

Annals of Surgical Oncology

Volumn 20, Issue 13, 2013, Pages 4063-4066

  Scaife, Courtney L ^a   Hartz, Arthur ^b   Pappas, Lisa ^b   Pelletier, Peter ^c   He, Tao ^b   Glasgow, Robert E ^a   Mulvihill, Sean J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; HUMAN; INFECTIOUS COMPLICATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84892161224     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3267-0     Document Type: Article

References (24)

1. El-Tamer MB, Ward BM, Schifftner T, et al. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245(5): 665-71.
2. Longo WE, Virgo KS, Johnson FE, et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum. 2000;43(1):83-91.
3. Begg CB, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346(15):1138-44.
4. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6): 883-99.
5. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539-45.
6. Walker KG, Bell SW, Rickard MJ, et al. Anastomotic leakage is predictive of diminished survival after curative resection for colorectal cancer. Ann Surg. 2004;240(2):255-9.
7. Law WL, Choi HK, Lee YM, Ho JW. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol. 2007;14(9): 2559-66.
8. Hirai T, Yamashita Y, Mukaida H, et al. Poor prognosis in esophageal cancer patients with postoperative complications. Surg Today. 1998;28(6):576-9.
9. Roxburgh CS, Salmond JM, Horgan PG, et al. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg. 2009;249(5):788-93.
10. Roxburgh CS, Platt JJ, Leitch EF, et al. Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer. Ann Surg Oncol. 2011;18(4):997-1005.
11. Law WL, Choi HK, Lee YM, et al. Anastomotic leakage is associated with poor lone-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg. 2007;11(1):8-15.
12. Bell SW, Walker KG, Rickard MJ, et al. Anastomotic leakage after curative anterior resection results in a higher prevalence of local recurrence. Br J Surg. 2003;90(10):1261-6.
13. Change SC, Lin JK, Yang SH, et al. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer. Hepatogastroenterology. 2003;50(54):1898-902.
14. Tachibna M, Tabara H, Kotoh T, et al. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol. 1999;94(3):757-65.
15. Swicher SG, Homes EC, Hunt KK, et al. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg. 1996;112(2):341-8.
16. Ito H, Are C, Gonen M, et al. Effect of postoperative morbidity on long-term survival after hepative resection for metastatic colorectal cancer. Ann Surg. 2008;247(6):994-1002.
17. Farid SG, Aldouri A, Morris-Stiff G, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251(1):91-100.
18. Gomez D, Morris-Stiff G, Wyatt J, et al. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 2008;98(5):371-6.
19. Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250(5):798-807.
20. Lagarde SM, de Boer JD, ten Kate FJ, et al. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008;247(1):71-6.
21. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6 Suppl 16):15-8.
22. Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol. 2006;90:1-50.
23. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149-63.
24. Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med. 2006;79(3-4):123-30.